HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
Diaphragm muscle from SU9516 treated dystrophin deficient mouse showing nuclei , myofibers and regenerating muscle fibers.Burkin lab at the University of Nevada, Reno School of Medicine

Potential Drug to Treat Muscular Dystrophy

NCATS researchers and collaborators demonstrated that an unsuccessful cancer drug may have new life as a potential treatment for Duchenne Muscular Dystrophy.

Work with Us

NCGC is highly collaborative and always encourages new partnership opportunities, including projects with NIH and external researchers as well as disease foundations and biotechnology companies. Learn more about how to work with us.

NCATS Chemical Genomics Center (NCGC)

NCGC researchers advance small molecule therapeutic development through assay (test) design, high-throughput screening and medicinal chemistry. Learn more.

Find NCATS Programs & InitiativesAccess NCATS Expertise & Resources

About NCGC

Find out more about how NCGC experts help discover novel small molecule therapies across the spectrum of human diseases.

Scientific Capabilities

Access a collaborative team of experts in assay development, high-throughput screening, medicinal chemistry, informatics and drug development.

Work with NCGC

Learn how to collaborate with NCGC staff to pursue a drug target or screen of interest.

      Unique NCGC Team Structure

      NCGC is composed of three drug discovery teams, each with dedicated biologists, chemists and informatics scientists. These teams are uniquely designed to handle small molecule discovery efforts, including early assay optimization, state-of-the-art high-throughput screening, early hit selection, advanced medicinal chemistry driven by structure-activity relationships, virtual screening, and molecular modeling and docking. Each team showcases specialized areas of expertise to cover a wide spectrum of biological targets and human pathologies. Learn more about the teams.